Dr. Eric Z. Berkowitz, MD

Dr. Berkowitz practices at Eric Berkowitz MD in New York, New York.

Dr. Berkowitz's NPI, 1679670491, was assigned on September 20, 2006. Dr. Berkowitz graduated from Albert Einstein College of Medicine in 2001. Dr. Berkowitz holds New York license 227527.

Dr. Berkowitz's primary practice is Eric Berkowitz MD, at 390 W End Ave, New York, NY 10024 in New York County. The practice phone is (917) 453-8072.

Dr. Berkowitz's primary practice is Eric Berkowitz MD in New York, New York. The medical group on file is Berkowitz Dermatology. Dmand AI also links Dr. Berkowitz to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Berkowitz practices. Vendor and product names are available with a free account.

Dermatology is Dr. Berkowitz's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Berkowitz is board certified in dermatology by the American Board of Dermatology. Dr. Berkowitz is licensed in New York.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and hives among the conditions Dr. Berkowitz treats.

CMS data shows 1,678 Medicare services from Dr. Berkowitz across 15 procedure codes in 2024, for 485 Medicare patients. Medicare paid $94,076 for them. Every service was in an office.

CMS counts 485 Medicare patients who saw Dr. Berkowitz in 2024. The largest group is 75 to 84, with 225 patients. 75% of them have high cholesterol, and 53% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.82, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Berkowitz's median patient age at 49, with 55% women.

In 2024, Dr. Berkowitz wrote 534 Medicare Part D claims for 224 patients. 92% of them were for generic drugs. CMS names the drug for 429 of them, across 14 drugs with 11 or more claims each, at $12,739 in total drug cost. In 2023, CMS named 392 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Berkowitz for performance year 2024, reported individually. Dr. Berkowitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 201 procedures of skin biopsy by Dr. Berkowitz, more than 85% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Berkowitz. The most frequent topics are Carcinoma, Squamous Cell and Skin Neoplasms. Dr. Berkowitz's most frequent co-authors are Robin R. Blum, MD and Mark Gabriel Lebwohl.

CMS Open Payments shows 519 general payments to Dr. Berkowitz from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Merz North America, Inc. paid the most, $1,090.

Dmand AI lists 3 awards for Dr. Berkowitz, most recently Top Doctors: New York Metro Area in 2014.

Dr. Berkowitz graduated from Albert Einstein College of Medicine in 2001. Dr. Berkowitz is a member of ASDS.

Dr. Berkowitz is in network with 12 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.